Seriously?
Has anyone actually read the report?
With final approval for HIV trials, and Sars Cov 2 infected mice getting a taste of BIT's antivirals, all fitting comfortably within a timeline that could spike the price beyond a lowly 25 cents a week or two before November 29th.
The debate should be whether or not those 5 million options get dumped onto the market as soon as we hit 25 cents.
